Alvimedica @ the EuroPCR 2021: “Empowering DES performance in complex patients to maximise efficacy and safety outcomes"

In this Case-in-Point session, they have been discussed the following points:
- identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients
- understand how re-PCI impacts on complex patients and complex PCI
- understand the added value of Cre8™ EVO unique technologies in diabetes mellitus and high bleeding risks patients
 
FACILITATOR: M. Valgimigli
CHATMASTER: I.F. Edes
SPEAKERS: A. Colombo, R. Romaguera, G. Sardella, P. Stella